HPR95 Inflation Reduction Act: Assessing the Impact for New Drug Development, Launch, Life Cycle Management and Loss of Exclusivity
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1242
https://www.valueinhealthjournal.com/article/S1098-3015(23)01342-6/fulltext
Section Title :
Section Order :
10674
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01342-6&doi=10.1016/j.jval.2023.03.1242